Tag: talicabtagene autoleucel
Cipla partners ImmunoACT to launch talicabtagene autoleucel, an anti-CD19 CAR-T cell...
Under this partnership, Cipla will commercialize talicabtagene autoleucel, India’s first indigenously developed CAR-T cell therapy, in the Republic of South Africa, Algeria, and Morocco